Innovent Biologics, Inc. (IVBXF)

Innovent Biologics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	22,089	7,719	8,875	6,592	9,047	14,845
Market Cap Growth	115.18%	-13.03%	34.63%	-27.13%	-39.06%	244.95%
Enterprise Value	21,223	6,988	8,174	5,758	7,612	14,106
Last Close Price	13.65	4.50	4.92	4.29	6.15	10.25
PS Ratio	13.85	5.98	10.14	9.98	13.46	25.21
PB Ratio	10.97	4.30	5.02	4.24	5.56	11.04
P/TBV Ratio	12.14	4.40	5.04	4.25	5.57	11.04
P/FCF Ratio	-	175.32	-	-	-	-
P/OCF Ratio	-	43.78	425.78	-	-	-
EV/Sales Ratio	13.21	5.41	9.34	8.72	11.33	23.96
EV/EBITDA Ratio	107.12	2126.28	-	-	-	-
EV/FCF Ratio	-	158.73	-	-	-	-
Debt / Equity Ratio	0.23	0.22	0.29	0.30	0.24	0.14
Debt / EBITDA Ratio	2.29	50.93	-	-	-	-
Debt / FCF Ratio	-	8.81	-	-	-	-
Asset Turnover	0.52	0.45	0.33	0.27	0.30	0.40
Inventory Turnover	2.97	2.69	1.51	1.00	1.19	1.45
Quick Ratio	2.25	2.08	2.68	2.78	3.27	5.85
Current Ratio	2.61	2.35	3.00	3.29	3.79	6.37
Return on Equity (ROE)	8.43%	-0.74%	-8.84%	-20.70%	-28.56%	-14.75%
Return on Assets (ROA)	3.44%	-0.82%	-5.12%	-11.54%	-12.04%	-3.65%
Return on Capital (ROIC)	4.49%	-1.08%	-6.49%	-14.57%	-14.81%	-4.46%
Earnings Yield	0.72%	-0.17%	-1.63%	-4.79%	-4.75%	-1.03%
FCF Yield	-	0.57%	-1.54%	-6.19%	-5.38%	-0.82%
Buyback Yield / Dilution	-3.74%	-4.35%	-4.67%	-2.37%	-7.27%	-15.23%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.